The University of Chicago Header Logo

Connection

Suzanne Conzen to Tamoxifen

Back to Details
This is a "connection" page, showing publications Suzanne Conzen has written about Tamoxifen.
Suzanne Conzen
Connection Strength
0.230
Tamoxifen
  1. Current status of selective estrogen receptor modulators (SERMs). Cancer J. 2003 Jan-Feb; 9(1):4-14.
    View in: PubMed
    Score: 0.197
  2. Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma. Cancer. 1996 Nov 01; 78(9):1906-11.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.